AcelRx Pharmaceuticals Inc. (ACRX)

2.18
0.01 0.46
NASDAQ : Health Technology
Prev Close 2.19
Open 2.20
Day Low/High 2.02 / 2.22
52 Wk Low/High 1.99 / 5.05
Volume 1.52M
Avg Volume 1.43M
Exchange NASDAQ
Shares Outstanding 78.91M
Market Cap 182.29M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Stocks Under $10 Weekly Summary

Last week we re-initiated a position in Aurora Cannabis, exited USA Technologies and added to our holdings in Del Frisco's Restaurant Group.

Stocks Under $10 Weekly Summary

We added a starter a position in Parateum Corp. during a challenging week for the portfolio.

Stocks Under $10 Weekly Summary

We added 2 new positions last week as the portfolio finished the summer strong.

Stocks Under $10 Weekly Summary

Last week was a busy one for the portfolio as we exited 3 positions.

Stocks Under $10 Weekly Summary

There were several bright spots in the portfolio last week, including Habit Restaurants and USA Technologies.

Stocks Under $10 Weekly Summary

The portfolio had several big winners last week as shares of Habit Restaurants and Energy Recovery soared.

A Positive Reaction For These Two Companies Following Q2 Earnings

While ArcelRx Pharmaceuticals faces key milestones, I'm excited about Energy Recovery.

Stocks Under $10 Weekly Summary

We trimmed one position and added to another last week as smaller-cap stocks took a hit.

Stocks Under $10 Weekly Summary

During a week that showed little change for the major stock market indices, the portfolio had a number of outperformers.

Stocks Under $10 Weekly Summary

Similar to the Russell 2000 trading off last week so too did a number of our holdings, although there were bright spots as well.

Update and Target Change on Healthcare Holding

Winning position AcelRx recently announced a public offering.

Updates on 8 Portfolio Positions

A look at several of our positions over the past week.

Stocks Under $10 Weekly Summary

It was a challenging week for the portfolio amid continued trade and tariff concerns.

Stocks Under $10 Weekly Summary

It was a good week for the portfolio, as a large majority of positions outperformed the market.

Stocks Under $10 Weekly Summary

Last week, we initiated a position in Farmland Partners and trimmed our holdings in AcelRx Pharmaceuticals.

Trimming a Position on Strength

We will sell some of our AcelRx holdings as the stock moves through out current price target.

Read All About It! Positive News on Four Positions

We still like all of these names after developments this week.

Stocks Under $10 Weekly Summary

During the week we scaled into two existing positions and added back shares of a former holding.

Stocks Under $10 Weekly Summary

During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.

Stocks Under $10 Weekly Summary

Last week we trimmed USA Technologies and added LendingClub to the Bullpen.

Trimming This Specialty Pharmaceutical Name

ACRX has reached our price target, so we’re being disciplined.

Stocks Under $10 Weekly Summary

We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.

Stocks Under $10 Weekly Summary

We added 2 new positions during a week of solid performance for the portfolio.

Stocks Under $10 Weekly Summary

We added to three positions during a mixed week for the market.

Stocks Under $10 Weekly Summary

During a down week for the market, we exited one name and added to another.

Finally Significant News on a Health Care Position

Here’s our plan for AcelRx Pharmaceuticals leading up to earnings.

Stocks Under $10 Weekly Summary

We initiated one position and closed out another last week.

Stocks Under $10 Weekly Summary

We added to two positions during a week when nearly all of our holdings moved higher.

Stocks Under $10 Weekly Summary

We exited one name and added to another during a wild week for stocks.

Stocks Under $10 Weekly Summary

The portfolio had several market outperformers last week and we took some profits in one high-flying position.

TheStreet Quant Rating: D- (Sell)